1. Home
  2. KORE vs ONCY Comparison

KORE vs ONCY Comparison

Compare KORE & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORE Group Holdings Inc.

KORE

KORE Group Holdings Inc.

HOLD

Current Price

$9.18

Market Cap

89.6M

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.79

Market Cap

98.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KORE
ONCY
Founded
2003
1998
Country
United States
Canada
Employees
539
29
Industry
Telecommunications Equipment
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.6M
98.7M
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
KORE
ONCY
Price
$9.18
$0.79
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$5.00
$7.33
AVG Volume (30 Days)
28.9K
1.1M
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.96
N/A
Revenue Next Year
N/A
$2,505.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$0.33
52 Week High
$9.22
$1.51

Technical Indicators

Market Signals
Indicator
KORE
ONCY
Relative Strength Index (RSI) 71.36 33.09
Support Level $4.10 N/A
Resistance Level $9.22 $1.18
Average True Range (ATR) 0.03 0.05
MACD -0.02 -0.01
Stochastic Oscillator 51.62 12.01

Price Performance

Historical Comparison
KORE
ONCY

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: